Eur J Neurosci 26(4):820827 Traina G (2016) The neurobiology of acetyl-L-carnitine
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss
Exenatide: Available in both twice-daily and weekly injection forms, Exenatide is one of the earlier medications in this category
Managing Side Effects Without Splitting Your Dose If nausea, constipation, or other side effects are difficult to manage, several evidence-based strategies work better than dose splitting
41.00 An analogue of naturally existing alpha-melanocyte hormone, Melanotan 2 is one of the most innovative tanning peptides presently available in the marketplace
Figure 4 5 Conclusions Incretin receptor agonists including GLP-1R agonists and dual GLP-1R/GIPR co-agonists reduce food intake and drive weight loss in patients with obesity